# MRI-guided Lateral Lymph Node Dissection in Rectal Cancer

> **NCT04850027** · — · UNKNOWN · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 268 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** TME+Lateral lymph node dissection.

## Key facts

- **NCT ID:** NCT04850027
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 268 (ESTIMATED)
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04850027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04850027, "MRI-guided Lateral Lymph Node Dissection in Rectal Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04850027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*